Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Westermann

Showing results (141-150 of 532) with videos related to

Pageof 54
Sort By:
Vascular Medicine (London, England)|September 20, 2024
Clinical outcomes in patients with chronic limb-threatening ischemia and infected ulcers following endovascular therapy are pathogen dependent: A single-center experience from 2012 to 2021Jonas Salm, Franziska Ikker, Tanja Böhme, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 3, 2006
Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenonCarsten Tschöpe, Dirk Westermann, Paul Steendijk, et al.
Journal of the American Heart Association|September 2, 2017
High Perforin-Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long-Term Mortality in Patients With Inflammatory CardiomyopathyFelicitas Escher, Uwe Kühl, Dirk Lassner, et al.
Canadian Journal of Physiology and Pharmacology|June 3, 2008
Additional lack of iNOS attenuates diastolic dysfunction in aged ET-1 transgenic micePhilipp Kalk, Dirk Westermann, Sophia Herzfeld, et al.
Plos One|July 9, 2015
Risk Factors of Coronary Artery Disease in Secondary Prevention--Results from the AtheroGene--StudyElvin Zengin, Christoph Bickel, Renate B Schnabel, et al.
Current Problems in Cardiology|August 26, 2022
Serum Lipoprotein(a) and 3-Year Outcomes in Patients Undergoing Percutaneous Coronary InterventionNoé Corpataux, Willibald Hochholzer, Christian Marc Valina, et al.
The Cochrane Database of Systematic Reviews|February 24, 2025
Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysisSamer Al Said, Klaus Kaier, Edris Nury, et al.
JACC. Cardiovascular Interventions|May 24, 2023
3-Year Outcomes of Transcatheter Aortic Valve Replacement: Insights From the PORTICO I RegistryFrancesco Maisano, Holger Thiele, Stephan Fichtlscherer, et al.
Journal of Cardiovascular Development and Disease|November 25, 2021
Differences in the Treatment of Acute Coronary Syndrome in the Pre-COVID and COVID Era: An Analysis from Two German High-Volume CentersDennis Eckner, Eva M Hofmann, Fadil Ademaj, et al.
Scientific Reports|October 19, 2022
Hospital intervention volume affects outcomes of emergency transcatheter aortic valve implantations in GermanyVera Oettinger, Adrian Heidenreich, Klaus Kaier, et al.
Pageof 54

Showing results (141-150 of 532) with videos related to

Sort By:
Pageof 54
Vascular Medicine (London, England)|September 20, 2024
Clinical outcomes in patients with chronic limb-threatening ischemia and infected ulcers following endovascular therapy are pathogen dependent: A single-center experience from 2012 to 2021Jonas Salm, Franziska Ikker, Tanja Böhme, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 3, 2006
Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenonCarsten Tschöpe, Dirk Westermann, Paul Steendijk, et al.
Journal of the American Heart Association|September 2, 2017
High Perforin-Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long-Term Mortality in Patients With Inflammatory CardiomyopathyFelicitas Escher, Uwe Kühl, Dirk Lassner, et al.
Canadian Journal of Physiology and Pharmacology|June 3, 2008
Additional lack of iNOS attenuates diastolic dysfunction in aged ET-1 transgenic micePhilipp Kalk, Dirk Westermann, Sophia Herzfeld, et al.
Plos One|July 9, 2015
Risk Factors of Coronary Artery Disease in Secondary Prevention--Results from the AtheroGene--StudyElvin Zengin, Christoph Bickel, Renate B Schnabel, et al.
Current Problems in Cardiology|August 26, 2022
Serum Lipoprotein(a) and 3-Year Outcomes in Patients Undergoing Percutaneous Coronary InterventionNoé Corpataux, Willibald Hochholzer, Christian Marc Valina, et al.
The Cochrane Database of Systematic Reviews|February 24, 2025
Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysisSamer Al Said, Klaus Kaier, Edris Nury, et al.
JACC. Cardiovascular Interventions|May 24, 2023
3-Year Outcomes of Transcatheter Aortic Valve Replacement: Insights From the PORTICO I RegistryFrancesco Maisano, Holger Thiele, Stephan Fichtlscherer, et al.
Journal of Cardiovascular Development and Disease|November 25, 2021
Differences in the Treatment of Acute Coronary Syndrome in the Pre-COVID and COVID Era: An Analysis from Two German High-Volume CentersDennis Eckner, Eva M Hofmann, Fadil Ademaj, et al.
Scientific Reports|October 19, 2022
Hospital intervention volume affects outcomes of emergency transcatheter aortic valve implantations in GermanyVera Oettinger, Adrian Heidenreich, Klaus Kaier, et al.
Pageof 54